FMRP-deficient brain by Darnell et al. 7 . In addition, no evidence was provided to directly link the loss of FMRP-mediated ribosomal stalling specifically to synaptic dysfunction in FXS. These topics represent important new directions for future investigations.
At present there are no specific treatments available for FXS in humans. One prominent hypothesis derived from animal model studies-the 'mGluR theory of fragile X'-posits that excessive protein synthesis of synaptic plasticity-gating proteins (of unknown number and identity) occurs in response to group I metabotropic glutamate receptor (mGluR) activation in the absence of FMRP 9, 10 . The excessive production of these proteins is proposed to underpin aberrant neuronal function in FXS. In fact, treatment with mGluR5 negative allosteric modulators such as MPEP and genetic reduction of mGluR5 levels can ameliorate some but not all symptoms in FXS mouse models 11, 12 . On the heels of this promising work in animal models, various new selective mGluR5 negative allosteric modulators are currently in clinical trials for people with FXS 13 .
The study by Darnell et al. 7 identified mGluR5 as a key target of FMRP, thus providing strong support for the mGluR theory. More important, the identification of numerous FMRP targets involved in synaptic development and function strongly suggests a broader synaptic function and/or plasticity defect mechanism for FXS ( Fig. 1) and may open new avenues for developing effective treatments for FXS. For several other key targets identified by Darnell et al. 7 such as NMDA (N-methyl-D-aspartate) receptors and GABA (γ-aminobutyric acid) receptors, which have crucial roles in regulating synaptic plasticity and neuronal activity, drugs modulating their function are already available or under development for other nervous system conditions. In light of this study, these existing compounds may find new indications for FXS and related disorders.
Interestingly, approximately 25% of individuals with FXS also show some degree of autistic behaviors 14 . As such, FXS is the leading known cause of autism linked to dysfunction of a single gene. Thus, efforts aimed at understanding the nature of brain dysfunction in FXS can provide valuable insights concerning several poorly understood neurodevelopmental disorders comprising a group termed the autism spectrum disorders (ASDs). Recently, synaptic dysfunction has emerged as a leading hypothesis for neural mechanisms of ASDs 15 . A comparison of the newly identified set of FMRP target transcripts with more than one hundred autism and ASD candidate genes from the Simons Foundation Autism Research Initiative (SFARI) database revealed significant overlap with several prominent autism and ASD candidate genes, including those encoding Shank3, neurexin-1 and neuroligin-3 (ref. 7) .
It is also striking that the three most commonly detected duplications linked to ASDs were each found to encompass at least one or more of the FMRP gene targets identified by the CLIP methodology-despite spanning variable numbers of genes 7 . These findings provide a clear molecular mechanism linking FMRP function to the development of autistic symptoms common to FXS and ASDs. Such insights have provided clear avenues for continued basic research and may hasten progress in translational research efforts aimed at filling the important unmet clinical need of providing effective treatments for these debilitating neurodevelopmental disorders.
Knowledge of brain development has advanced with detailed understanding about neuronal birth and specification, axonal extension and synapse formation, den- 
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The mystery of developing connections
Jeffrey L Neul dritic pruning, myelination and regional brain specification. These events are characterized by both progressive and regressive processes, which occur in a ages. Characterizing the network properties and development of functional networks in these forms of NDD may allow further classification of people with idiopathic forms of autism. Additionally, as animal models exist for these disorders, there may be opportunities to discover the cellular and molecular basis of the abnormal development of these functional networks. Finally, clustering those cases of idiopathic autism on the basis of their functional connectivity would create more homogeneous clinical populations to further discover the exact etiology of the specific NDD.
The exact biological basis of the development of functional connectivity is still an open question. Strictly anatomical developmental changes are clearly important for dispersed brain regions to form functional connections. But there is additional complexity that arises in neural circuits, as many functional pathways do not have
back to front' within the brain 1 . Beyond these structural relationships, functional connections exist between brain regions. Recent work has now raised questions about the biological basis and the development of these functional connections and how they can be altered by consciousness, drugs and disease states.
Functional connectivity within the brain represents neuronal activity in spatially distinct regions and is characterized using resting-state functional-connectivity magnetic resonance imaging (fc-rsMRI) 2 . This method measures resting, spontaneous, low-frequency fluctuations in oxygen levels in blood within the brain, which correlates with regional changes in neuronal activation. Correlations of this signal across spatially distinct brain regions define resting-state networks (RSNs), whose characterization has attracted attention because the information can be acquired in a short time, there is no need for the subject to participate in any specific task and the information obtained is robust across scans captured at different locations and with various states of consciousness 3 .
How do these RSNs change during normal development, and how might they be altered in neurodevelopmental diseases (NDDs) such as autism? Several studies indicate that a developmental pattern of functional connectivity continues throughout childhood and up to young adulthood 4, 5 . In general, infants show developed local networks; however, longerrange front-to-back connections important for more complicated networks, such as executive control and the default mode network, strengthen, and local connections decrease, as development proceeds (Fig. 1) .
Although the pattern of functional connectivity development can be defined, ways to determine the developmental state of functional networks for a specific individual have been lacking. Recently, Dosenbach et al. 6 used a form of supervised computer learning to predict the functional connectivity 'maturity' of individual brains (Fig. 1) . Using these techniques, Dosenbach et al. 6 were able to generate a "functional brain maturation curve," similar to a standard growth curve used to assess weight gain in children. This suggests the possibility that there is a simple way to assess overall brain function and maturation and compare it in a meaningful fashion with known standardized growth curves, similar to what is now done for height, weight and head size.
This study will have a considerable impact on translational research on NDDs such as autism, as it may be used to characterize the functional connectivity development of affected individuals and to determine where they fall on the brain functional maturation curve. To date, characterization of the rs-fcMRI of a number of NDDs, including autism 7 , attention-deficit/hyperactivity disorder (ADHD) 8 and Tourette's syndrome 9 , have found aberrant functional network structure in these disorders, but the developmental trajectory of these disorders is currently unknown (Fig. 1) .
The early identification of affected individuals poses a challenge, and one current approach aims to study at-risk individuals, including siblings of known affected individuals. But a promising approach would be studying the developmental trajectory of NDD with known genetic causes, such as Rett, Fragile X and Angelman's syndromes, which are increasingly identified through molecular testing at very young Enhance functional connectivity?
Manipulate speci c neuronal activity Figure 1 Development of functional networks. Brain functional connectivity proceeds along a growth curve characterized by Dosenbach et al. 5 . Local connections predominate in children; however, they diminish in strength over time while longer-range, front-to-back connections strengthen. In NDDs, such as autism, functional networks are abnormal. Currently, it is unknown whether this results from a failure of the functional networks to mature or an aberrant pathway of development. Functional connectivity networks are being characterized in animal models using rs-fcMRI. Mouse models of NDDs can be used to characterize the abnormal formation of functional connectivity and to define development of these networks. Advanced techniques, such as optogenetics, can be used to either inhibit or drive specific neuronal activity in discrete anatomical regions to study their role in functional connectivity.
experimental techniques with rs-fcMRI in animal models and relating this to human rsfcMRI may help to bridge these organizational levels to better understand brain development during both health and disease.
ronal properties at different time points and locations with currently available advanced techniques, such as optogenetics 14 , while monitoring the functional connectivity of a specified network will help establish the formal relationship between specific cell populations and their firing patterns and the overall network properties 15 (Fig. 1) . Furthermore, characterizing functional connectivity in mouse models of NDD would allow correlation to network alterations in these diseases, providing a system to determine the structural and functional changes that underlie these disorders and to develop efficacious drugs.
A major challenge in neuroscience has been to develop methods to assay and bridge information between different levels of circuit organization. Although considerable advances have furthered our understanding of how molecular, cellular, and electrical processes within a cell relate to the functioning of a local neural circuit, we are just now beginning to have tools capable of relating local to global changes in functional connectivity and, ultimately, to behavior. Perhaps combining these direct monosynaptic structural connections but rather are generated across multiple synaptic connections. Additionally, functional networks can be reversibly altered by nonstructural mechanisms. For example, altering neuromodulatory neurotransmitters such as dopamine 10 or serotonin 11 can modulate functional connectivity in disease states. Thus, although anatomical changes are clearly important in the formation of functional networks, additional nonanatomical features are also crucial.
Although further understanding of the biological basis of the development of functional connectivity will be gained from human studies, ultimately more tractable systems will need to be used. rs-fcMRI has been developed in animal models including rats 12 and recently mice 13 , and the first requirement for each will be to establish the developmental trajectory of functional networks. Thus, characterization and manipulation of specific cellular developmental processes and molecular changes that occur in discrete anatomical regions can be correlated with changes in functional connectivity. Alteration of neu-
